Galectin-8 Downmodulates TLR4 Activation and Impairs Bacterial Clearance in a Mouse Model of Pseudomonas aeruginosa

Abdulraouf Ramadan1, Zhiyi Cao1, Mujtaba Hassan2

  • 1New England Eye Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, MA.

Insights

Galectin-8 (Gal-8) suppresses the innate immune response to Pseudomonas aeruginosa keratitis. Inhibiting Gal-8 enhances bacterial clearance and reduces infection severity, offering new therapeutic targets.

Area of Science:

  • Immunology
  • Microbiology
  • Ophthalmology

Background:

  • Pseudomonas aeruginosa causes severe keratitis, a difficult-to-treat corneal infection.
  • The innate immune response plays a critical role in controlling P. aeruginosa infections.

Purpose of the Study:

  • To investigate the role of galectin-8 (Gal-8) in regulating the innate immune response during P. aeruginosa keratitis.
  • To evaluate Gal-8 as a potential therapeutic target for P. aeruginosa keratitis.

Main Methods:

  • Utilized a mouse model of P. aeruginosa keratitis.
  • Assessed the impact of Gal-8 deficiency on infection susceptibility and immune cell function.
  • Investigated the effect of exogenous Gal-8 and a Gal-8 inhibitor on immune pathways and bacterial clearance.

Main Results:

  • Gal-8 deficient mice were resistant to P. aeruginosa keratitis, unlike mice deficient in other galectins.
  • Exogenous Gal-8 suppressed NF-κB activation and MD-2/TLR4 complex formation in macrophages.
  • Gal-8 deficient neutrophils exhibited enhanced reactive oxygen species production and bacterial killing capacity, which was reversed by exogenous Gal-8.
  • A Gal-8 inhibitor reduced infection severity in the mouse model.

Conclusions:

  • Galectin-8 downmodulates the innate immune response by suppressing TLR4 pathway activation and neutrophil-mediated bacterial clearance.
  • Targeting Gal-8 presents a promising therapeutic strategy for P. aeruginosa keratitis and potentially other hyperactive immune conditions.